Streetbeat News

Stock Prices

CGNT

Cognyte Software reported better-than-expected Q2 2025 results with an adjusted EPS of $0.05, surpassing the estimated loss of $(0.02). The company's sales also exceeded expectations, reaching $84.413 million compared to the $83.694 million estimate.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 11:01 am

BA

GCAD

ITA

Boeing has informed suppliers of a six-month delay in reaching a key production milestone for its 737 MAX, now targeting March 2025 for a monthly output of 42 jets. This delay highlights ongoing production challenges. Additionally, Boeing faces potential labor unrest as union members vote on a tentative agreement.

Portfolio Pulse from Lekha Gupta

September 10, 2024 | 10:57 am

AMZN

ORCL

Oracle shares surged by 8.8% in pre-market trading after reporting better-than-expected earnings and sales for Q1. Additionally, Oracle and Amazon's AWS launched Oracle Database@AWS, enhancing Oracle's cloud offerings. Other stocks like Silexion Therapeutics and Quoin Pharmaceuticals also saw significant pre-market movements.

Portfolio Pulse from Avi Kapoor

September 10, 2024 | 10:41 am

GOOGL

IYF

PLTR

XOM

On CNBC's 'Final Trades,' experts discussed various stocks. iShares U.S. Financials ETF was highlighted by Shannon Saccocia. Exxon Mobil withdrew from a potential acquisition in Namibia. Alphabet faces scrutiny from the UK's CMA over ad tech practices. Palantir Technologies was added to the S&P 500, boosting its stock price.

Portfolio Pulse from Avi Kapoor

September 10, 2024 | 10:33 am

ROIV

Pulmovant, a subsidiary of Roivant, presented data from the Phase 1B ATMOS1 study of Mosliciguat, an inhaled sGC activator for pulmonary hypertension. The study focuses on targeted lung delivery and once-daily administration.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 10:33 am

AAPL

Apple's Glowtime event, featuring the iPhone 16 with AI capabilities, failed to impress compared to AI competitors. Despite new features, the event did not generate significant excitement, leading to a dip in Apple's stock price. Analysts suggest Apple's strategy focuses on enhancing user experience rather than rushing AI advancements.

Portfolio Pulse from Navdeep Yadav

September 10, 2024 | 10:31 am

CNC

Centene plans to reaffirm its 2024 adjusted EPS guidance of over $6.80, with a shift of 20 to 30 cents of EPS from Q3 to Q4. Q3 EPS is projected at $1.31-$1.41, below the estimated $1.51. The company is optimistic about its Medicare Advantage stars program.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 10:17 am

XCH

XCHG Limited, an EV charging solutions provider, has announced the pricing of its IPO, offering 3.33 million ADSs at $6.2 each. The ADSs, representing 40 Class A ordinary shares, will trade on Nasdaq under the symbol 'XCH'. The offering is expected to close on September 11, 2024.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 10:02 am

MAIA

MAIA Biotechnology reports promising interim survival data from its Phase 2 trial of THIO, a telomere-targeting treatment for advanced non-small cell lung cancer. The trial shows improved survival rates, with some patients surpassing 12 months of survival. Full efficacy results are expected later this year.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 10:02 am

TSLA

Tesla's Cybertruck durability is questioned after a video shows it sustaining damage from driving through a fence. Tesla engineer Wes Morrill attributes the damage to the removal of stock parts and announces upcoming retrofit options for added protection.

Portfolio Pulse from Anan Ashraf

September 10, 2024 | 9:59 am